Cargando…
A Cell-Based Platform for the Investigation of Immunoproteasome Subunit β5i Expression and Biology of β5i-Containing Proteasomes
The degradation of most intracellular proteins is a dynamic and tightly regulated process performed by proteasomes. To date, different forms of proteasomes have been identified. Currently the role of non-constitutive proteasomes (immunoproteasomes (iPs) and intermediate proteasomes (intPs)) has attr...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616536/ https://www.ncbi.nlm.nih.gov/pubmed/34831272 http://dx.doi.org/10.3390/cells10113049 |
_version_ | 1784604372615823360 |
---|---|
author | Burov, Alexander Funikov, Sergei Vagapova, Elmira Dalina, Alexandra Rezvykh, Alexander Shyrokova, Elena Lebedev, Timofey Grigorieva, Ekaterina Popenko, Vladimir Leonova, Olga Spasskaya, Daria Spirin, Pavel Prassolov, Vladimir Karpov, Vadim Morozov, Alexey |
author_facet | Burov, Alexander Funikov, Sergei Vagapova, Elmira Dalina, Alexandra Rezvykh, Alexander Shyrokova, Elena Lebedev, Timofey Grigorieva, Ekaterina Popenko, Vladimir Leonova, Olga Spasskaya, Daria Spirin, Pavel Prassolov, Vladimir Karpov, Vadim Morozov, Alexey |
author_sort | Burov, Alexander |
collection | PubMed |
description | The degradation of most intracellular proteins is a dynamic and tightly regulated process performed by proteasomes. To date, different forms of proteasomes have been identified. Currently the role of non-constitutive proteasomes (immunoproteasomes (iPs) and intermediate proteasomes (intPs)) has attracted special attention. Here, using a CRISPR-Cas9 nickase technology, four cell lines: histiocytic lymphoma, colorectal adenocarcinoma, cervix adenocarcinoma, and hepatocarcinoma were modified to express proteasomes with mCherry-tagged β5i subunit, which is a catalytic subunit of iPs and intPs. Importantly, the expression of the chimeric gene in modified cells is under the control of endogenous regulatory mechanisms and is increased following IFN-γ and/or TNF-α stimulation. Fluorescent proteasomes retain catalytic activity and are distributed within the nucleus and cytoplasm. RNAseq reveals marginal differences in gene expression profiles between the modified and wild-type cell lines. Predominant metabolic pathways and patterns of expressed receptors were identified for each cell line. Using established cell lines, we demonstrated that anti-cancer drugs Ruxolitinib, Vincristine and Gefitinib stimulated the expression of β5i-containing proteasomes, which might affect disease prognosis. Taken together, obtained cell lines can be used as a platform for real-time studies of immunoproteasome gene expression, localization of iPs and intPs, interaction of non-constitutive proteasomes with other proteins, proteasome trafficking and many other aspects of proteasome biology in living cells. Moreover, the established platform might be especially useful for fast and large-scale experiments intended to evaluate the effects of different conditions including treatment with various drugs and compounds on the proteasome pool. |
format | Online Article Text |
id | pubmed-8616536 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86165362021-11-26 A Cell-Based Platform for the Investigation of Immunoproteasome Subunit β5i Expression and Biology of β5i-Containing Proteasomes Burov, Alexander Funikov, Sergei Vagapova, Elmira Dalina, Alexandra Rezvykh, Alexander Shyrokova, Elena Lebedev, Timofey Grigorieva, Ekaterina Popenko, Vladimir Leonova, Olga Spasskaya, Daria Spirin, Pavel Prassolov, Vladimir Karpov, Vadim Morozov, Alexey Cells Article The degradation of most intracellular proteins is a dynamic and tightly regulated process performed by proteasomes. To date, different forms of proteasomes have been identified. Currently the role of non-constitutive proteasomes (immunoproteasomes (iPs) and intermediate proteasomes (intPs)) has attracted special attention. Here, using a CRISPR-Cas9 nickase technology, four cell lines: histiocytic lymphoma, colorectal adenocarcinoma, cervix adenocarcinoma, and hepatocarcinoma were modified to express proteasomes with mCherry-tagged β5i subunit, which is a catalytic subunit of iPs and intPs. Importantly, the expression of the chimeric gene in modified cells is under the control of endogenous regulatory mechanisms and is increased following IFN-γ and/or TNF-α stimulation. Fluorescent proteasomes retain catalytic activity and are distributed within the nucleus and cytoplasm. RNAseq reveals marginal differences in gene expression profiles between the modified and wild-type cell lines. Predominant metabolic pathways and patterns of expressed receptors were identified for each cell line. Using established cell lines, we demonstrated that anti-cancer drugs Ruxolitinib, Vincristine and Gefitinib stimulated the expression of β5i-containing proteasomes, which might affect disease prognosis. Taken together, obtained cell lines can be used as a platform for real-time studies of immunoproteasome gene expression, localization of iPs and intPs, interaction of non-constitutive proteasomes with other proteins, proteasome trafficking and many other aspects of proteasome biology in living cells. Moreover, the established platform might be especially useful for fast and large-scale experiments intended to evaluate the effects of different conditions including treatment with various drugs and compounds on the proteasome pool. MDPI 2021-11-05 /pmc/articles/PMC8616536/ /pubmed/34831272 http://dx.doi.org/10.3390/cells10113049 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Burov, Alexander Funikov, Sergei Vagapova, Elmira Dalina, Alexandra Rezvykh, Alexander Shyrokova, Elena Lebedev, Timofey Grigorieva, Ekaterina Popenko, Vladimir Leonova, Olga Spasskaya, Daria Spirin, Pavel Prassolov, Vladimir Karpov, Vadim Morozov, Alexey A Cell-Based Platform for the Investigation of Immunoproteasome Subunit β5i Expression and Biology of β5i-Containing Proteasomes |
title | A Cell-Based Platform for the Investigation of Immunoproteasome Subunit β5i Expression and Biology of β5i-Containing Proteasomes |
title_full | A Cell-Based Platform for the Investigation of Immunoproteasome Subunit β5i Expression and Biology of β5i-Containing Proteasomes |
title_fullStr | A Cell-Based Platform for the Investigation of Immunoproteasome Subunit β5i Expression and Biology of β5i-Containing Proteasomes |
title_full_unstemmed | A Cell-Based Platform for the Investigation of Immunoproteasome Subunit β5i Expression and Biology of β5i-Containing Proteasomes |
title_short | A Cell-Based Platform for the Investigation of Immunoproteasome Subunit β5i Expression and Biology of β5i-Containing Proteasomes |
title_sort | cell-based platform for the investigation of immunoproteasome subunit β5i expression and biology of β5i-containing proteasomes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616536/ https://www.ncbi.nlm.nih.gov/pubmed/34831272 http://dx.doi.org/10.3390/cells10113049 |
work_keys_str_mv | AT burovalexander acellbasedplatformfortheinvestigationofimmunoproteasomesubunitb5iexpressionandbiologyofb5icontainingproteasomes AT funikovsergei acellbasedplatformfortheinvestigationofimmunoproteasomesubunitb5iexpressionandbiologyofb5icontainingproteasomes AT vagapovaelmira acellbasedplatformfortheinvestigationofimmunoproteasomesubunitb5iexpressionandbiologyofb5icontainingproteasomes AT dalinaalexandra acellbasedplatformfortheinvestigationofimmunoproteasomesubunitb5iexpressionandbiologyofb5icontainingproteasomes AT rezvykhalexander acellbasedplatformfortheinvestigationofimmunoproteasomesubunitb5iexpressionandbiologyofb5icontainingproteasomes AT shyrokovaelena acellbasedplatformfortheinvestigationofimmunoproteasomesubunitb5iexpressionandbiologyofb5icontainingproteasomes AT lebedevtimofey acellbasedplatformfortheinvestigationofimmunoproteasomesubunitb5iexpressionandbiologyofb5icontainingproteasomes AT grigorievaekaterina acellbasedplatformfortheinvestigationofimmunoproteasomesubunitb5iexpressionandbiologyofb5icontainingproteasomes AT popenkovladimir acellbasedplatformfortheinvestigationofimmunoproteasomesubunitb5iexpressionandbiologyofb5icontainingproteasomes AT leonovaolga acellbasedplatformfortheinvestigationofimmunoproteasomesubunitb5iexpressionandbiologyofb5icontainingproteasomes AT spasskayadaria acellbasedplatformfortheinvestigationofimmunoproteasomesubunitb5iexpressionandbiologyofb5icontainingproteasomes AT spirinpavel acellbasedplatformfortheinvestigationofimmunoproteasomesubunitb5iexpressionandbiologyofb5icontainingproteasomes AT prassolovvladimir acellbasedplatformfortheinvestigationofimmunoproteasomesubunitb5iexpressionandbiologyofb5icontainingproteasomes AT karpovvadim acellbasedplatformfortheinvestigationofimmunoproteasomesubunitb5iexpressionandbiologyofb5icontainingproteasomes AT morozovalexey acellbasedplatformfortheinvestigationofimmunoproteasomesubunitb5iexpressionandbiologyofb5icontainingproteasomes AT burovalexander cellbasedplatformfortheinvestigationofimmunoproteasomesubunitb5iexpressionandbiologyofb5icontainingproteasomes AT funikovsergei cellbasedplatformfortheinvestigationofimmunoproteasomesubunitb5iexpressionandbiologyofb5icontainingproteasomes AT vagapovaelmira cellbasedplatformfortheinvestigationofimmunoproteasomesubunitb5iexpressionandbiologyofb5icontainingproteasomes AT dalinaalexandra cellbasedplatformfortheinvestigationofimmunoproteasomesubunitb5iexpressionandbiologyofb5icontainingproteasomes AT rezvykhalexander cellbasedplatformfortheinvestigationofimmunoproteasomesubunitb5iexpressionandbiologyofb5icontainingproteasomes AT shyrokovaelena cellbasedplatformfortheinvestigationofimmunoproteasomesubunitb5iexpressionandbiologyofb5icontainingproteasomes AT lebedevtimofey cellbasedplatformfortheinvestigationofimmunoproteasomesubunitb5iexpressionandbiologyofb5icontainingproteasomes AT grigorievaekaterina cellbasedplatformfortheinvestigationofimmunoproteasomesubunitb5iexpressionandbiologyofb5icontainingproteasomes AT popenkovladimir cellbasedplatformfortheinvestigationofimmunoproteasomesubunitb5iexpressionandbiologyofb5icontainingproteasomes AT leonovaolga cellbasedplatformfortheinvestigationofimmunoproteasomesubunitb5iexpressionandbiologyofb5icontainingproteasomes AT spasskayadaria cellbasedplatformfortheinvestigationofimmunoproteasomesubunitb5iexpressionandbiologyofb5icontainingproteasomes AT spirinpavel cellbasedplatformfortheinvestigationofimmunoproteasomesubunitb5iexpressionandbiologyofb5icontainingproteasomes AT prassolovvladimir cellbasedplatformfortheinvestigationofimmunoproteasomesubunitb5iexpressionandbiologyofb5icontainingproteasomes AT karpovvadim cellbasedplatformfortheinvestigationofimmunoproteasomesubunitb5iexpressionandbiologyofb5icontainingproteasomes AT morozovalexey cellbasedplatformfortheinvestigationofimmunoproteasomesubunitb5iexpressionandbiologyofb5icontainingproteasomes |